# Acadia Pharmaceuticals Inc: Form DEF 14A, filed Apr 25, 2025

- Company: [Acadia Pharmaceuticals Inc](/companies/acad.md) (CIK 1070494)
- Form: DEF 14A
- Filed: 2025-04-25
- Accepted by EDGAR: Apr 25, 2025, 16:49 ET
- Period: 2025-05-29
- Accession: 0000950170-25-058827
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070494/000095017025058827/acad-20250425.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070494/000095017025058827/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070494/000095017025058827/acad-20250425.htm

Filed Apr 25, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-058827. Last ingested by Listed: Nov 4, 2026, 17:11 ET. No prices; not investment advice.